Pharma firms go green
23 Sep 2015
A new renewable energy plant located in Cramlington, Northumberland will have an annual generating capacity of 223GWh, helping to power pharmaceuticals firms in the local area.
Aesica and MSD will benefit directly from the plant’s output, which will also feature a 27.7MW Combined Heat and Power (CHP) facility.
National Grid will also benefit from electricity generated at the £138 million plant, which has been developed by Estover Energy.
“Nearly £140m invested in the Cramlington CHP plant is fantastic news for the North East and for Estover,” said Marcus Whately, founder of Estover Energy.
The Green Investment Bank (GIB) and John Laing Investments have committed a combined £48 million to the project, while Barclays Bank will provide the remainder of the funding as debt.
“Working with GIB, John Laing and Estover to help deliver this deal further demonstrates our continued commitment to the UK renewable energy sector,” said Nial Gemmell, director at Barclays Bank.
The construction of the plant will be undertaken by Burmeister & Wain Energy A/S (BWE) and Burmeister & Wain Scandinavian Contractors A/S (BWSC). BWSC is expected to operate the plant upon completion.
Fuel for the plant will be provided by Stobart Biomass Products, plus local growers and forest industry suppliers.
